These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 18358099)
1. Identification of non-peptidic neuromedin U receptor modulators by a robust homogeneous screening assay. Meng T; Su HR; Binkert C; Fischli W; Zhou L; Shen JK; Wang MW Acta Pharmacol Sin; 2008 Apr; 29(4):517-27. PubMed ID: 18358099 [TBL] [Abstract][Full Text] [Related]
2. Development of a homogeneous calcium mobilization assay for high throughput screening of mas-related gene receptor agonists. Zhang R; Yan PK; Zhou CH; Liao JY; Wang MW Acta Pharmacol Sin; 2007 Jan; 28(1):125-31. PubMed ID: 17184592 [TBL] [Abstract][Full Text] [Related]
3. Functional characterization of cell lines for high-throughput screening of human neuromedin U receptor subtype 2 specific agonists using a luciferase reporter gene assay. Li X; Shen F; Zhang Y; Zhu J; Huang L; Shi Q Eur J Pharm Biopharm; 2007 Aug; 67(1):284-92. PubMed ID: 17337170 [TBL] [Abstract][Full Text] [Related]
4. Development of a complex scintillation proximity assay for high-throughput screening of PPARgamma modulators. Wu B; Gao J; Wang MW Acta Pharmacol Sin; 2005 Mar; 26(3):339-44. PubMed ID: 15715931 [TBL] [Abstract][Full Text] [Related]
6. Development of a universal high-throughput calcium assay for G-protein- coupled receptors with promiscuous G-protein Galpha15/16. Zhu T; Fang LY; Xie X Acta Pharmacol Sin; 2008 Apr; 29(4):507-16. PubMed ID: 18358098 [TBL] [Abstract][Full Text] [Related]
7. Signaling and ligand binding by recombinant neuromedin U receptors: evidence for dual coupling to Galphaq/11 and Galphai and an irreversible ligand-receptor interaction. Brighton PJ; Szekeres PG; Wise A; Willars GB Mol Pharmacol; 2004 Dec; 66(6):1544-56. PubMed ID: 15331768 [TBL] [Abstract][Full Text] [Related]
8. High-throughput screening of novel antagonists on melanin-concentrating hormone receptor-1. Yan JH; Li QY; Boutin JA; Renard MP; Ding YX; Hao XJ; Zhao WM; Wang MW Acta Pharmacol Sin; 2008 Jun; 29(6):752-8. PubMed ID: 18501123 [TBL] [Abstract][Full Text] [Related]
9. Rhodanine derivatives as novel peroxisome proliferator-activated receptor gamma agonists. Liu Q; Zhang YY; Lu HL; Li QY; Zhou CH; Wang MW Acta Pharmacol Sin; 2007 Dec; 28(12):2033-9. PubMed ID: 18031620 [TBL] [Abstract][Full Text] [Related]
10. Development of a homogeneous binding assay for histamine receptors. Crane K; Shih DT Anal Biochem; 2004 Dec; 335(1):42-9. PubMed ID: 15519569 [TBL] [Abstract][Full Text] [Related]
11. Development of a scintillation proximity assay binding method for the human 5-hydroxytryptamine 6 receptor using intact cells. Carrick T; Kowal D; Nawoschik S; Zhang G; Chan K; Dunlop J Anal Biochem; 2008 Oct; 381(1):27-32. PubMed ID: 18601889 [TBL] [Abstract][Full Text] [Related]
12. Screening and isolation of a natural dopamine D1 receptor antagonist using cell-based assays. Yu S; Park JS; Paredes V; Song MC; Baek NI; Lee SI; Lim JS; Cho NY; Yoon J; Baek K J Biotechnol; 2010 Feb; 145(3):304-9. PubMed ID: 19963021 [TBL] [Abstract][Full Text] [Related]
13. Identification of novel Kv1.3 blockers using a fluorescent cell-based ion channel assay. Slack M; Kirchhoff C; Moller C; Winkler D; Netzer R J Biomol Screen; 2006 Feb; 11(1):57-64. PubMed ID: 16314404 [TBL] [Abstract][Full Text] [Related]
14. Discovery and pharmacological characterization of a small-molecule antagonist at neuromedin U receptor NMUR2. Liu JJ; Payza K; Huang J; Liu R; Chen T; Coupal M; Laird JM; Cao CQ; Butterworth J; Lapointe S; Bayrakdarian M; Trivedi S; Bostwick JR J Pharmacol Exp Ther; 2009 Jul; 330(1):268-75. PubMed ID: 19369576 [TBL] [Abstract][Full Text] [Related]
15. Development of displacement binding and GTPgammaS scintillation proximity assays for the identification of antagonists of the micro-opioid receptor. Rodgers G; Hubert C; McKinzie J; Suter T; Statnick M; Emmerson P; Stancato L Assay Drug Dev Technol; 2003 Oct; 1(5):627-36. PubMed ID: 15090235 [TBL] [Abstract][Full Text] [Related]
16. Discovery of novel chemotypes to a G-protein-coupled receptor through ligand-steered homology modeling and structure-based virtual screening. Cavasotto CN; Orry AJ; Murgolo NJ; Czarniecki MF; Kocsi SA; Hawes BE; O'Neill KA; Hine H; Burton MS; Voigt JH; Abagyan RA; Bayne ML; Monsma FJ J Med Chem; 2008 Feb; 51(3):581-8. PubMed ID: 18198821 [TBL] [Abstract][Full Text] [Related]
17. Use of FLIPR membrane potential dyes for validation of high-throughput screening with the FLIPR and microARCS technologies: identification of ion channel modulators acting on the GABA(A) receptor. Joesch C; Guevarra E; Parel SP; Bergner A; Zbinden P; Konrad D; Albrecht H J Biomol Screen; 2008 Mar; 13(3):218-28. PubMed ID: 18270364 [TBL] [Abstract][Full Text] [Related]
18. Heterologous expression of human Neuromedin U receptor 1 and its subsequent solubilization and purification. Xia H; Liu L; Reinhart C; Michel H Biochim Biophys Acta; 2008 Oct; 1778(10):2203-9. PubMed ID: 18598671 [TBL] [Abstract][Full Text] [Related]
19. Development of a scintillation proximity assay for human insulin-like growth factor-binding protein 4 compatible with inhibitor high-throughput screening. Khawaja XZ Anal Biochem; 2007 Jul; 366(1):80-6. PubMed ID: 17482135 [TBL] [Abstract][Full Text] [Related]
20. Use of scintillation proximity assay to measure radioligand binding to immobilized receptors without separation of bound from free ligand. Berry J; Price-Jones M; Killian B Methods Mol Biol; 2012; 897():79-94. PubMed ID: 22674161 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]